Sanofi flies with anti-counterfeiting plan
This article was originally published in Scrip
Sanofi Aventis is tackling counterfeit medicines with an awareness campaign aimed at long haul Air France passengers flying around the globe. The firm says it wants to raise awareness among travellers about the dangers of counterfeit medicines and tell them how to protect themselves.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.